Teva To Pay Nevada $193 Million Over Role In Opioid Epidemic

Teva Pharmaceutical Industries (TEVA.TA) on Wednesday agreed to pay Nevada $193 million to settle claims that its marketing practices fueled opioid addiction, the state announced.

Read More

Court Seeks Compromise That Might Preserve Preventive Health Insurance Mandates As Appeals Play Out

Federal appeals court judges are seeking compromise on whether government requirements that health insurance include coverage for HIV prevention, cancer screenings and some other types of preventive care can be maintained while a legal battle over the mandates plays out.

Read More

A Windfall in Health Insurance Rebates? It’s Not as Crazy as It Sounds

Former Democratic Sen. Al Franken tweeted recently that Americans will receive “$1.1 B in rebates from health insurance companies this year” because of a provision he wrote into the Affordable Care Act.

Read More

‘Tantamount To Extortion’: Merck Sues U.S. Government Over Medicare Negotiation Program

Merck on Tuesday sued to stop the federal government from implementing a new Medicare drug price negotiation program. Merck called the negotiation process that Democrats designed in a law last August “a sham,” arguing that the federal government “dictates” prices. The company argues in the lawsuit that the Inflation Reduction Act is unconstitutional for two reasons. The ...

Read More

Southern Nevada Officials Clarify COVID Changes Post-Public Health Emergency

Just one year ago, the COVID-19 omicron variant was spreading in communities across the United States. That meant increased hospitalizations and deaths, which is why public health officials recommended updated vaccinations along with masking, social distancing and the other pandemic steps we’ve been taking since 2020. Although the federal COVID-19 public health emergency officially ended ...

Read More

FDA Chief’s Unwelcome Message To Biotech Execs: ‘Prices Of Drugs Are Too High’

The Food and Drug Administration’s top official Wednesday told a Boston gathering of biopharma industry leaders something few of them wanted to hear: Americans are paying too much for prescription medicines. ”The prices of drugs are too high in the US, and we have to come to grips with it,” FDA Commissioner Robert Califf told ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square